Analyst Ratings For IntelliPharmaCeutics Intl (NASDAQ:IPCI)
Today, HC Wainwright reiterated its Buy rating on IntelliPharmaCeutics Intl (NASDAQ:IPCI) with a price target of $2.50.
Some recent analyst ratings include
- 2/12/2018-HC Wainwright Reiterated Rating of Buy.
- 9/26/2017-Mackie Upgrade from a “Hold” rating to a “” rating.
- 4/18/2017-Aegis Reiterated Rating of Hold.
Recent Trading Activity for IntelliPharmaCeutics Intl (NASDAQ:IPCI)
Shares of IntelliPharmaCeutics Intl closed the previous trading session at 0.77 up +0.02 2.13% with 0.7549999952316284 shares trading hands.